Cumulative Exposure to Infliximab, But Not Trough Concentrations, Correlates With Rate of Infection

Landemaine, A; Petitcollin, A; Brochard, C; Miard, C; Dewitte, M; Le Balc'h, E; Grainville, T; Bellissant, E; Siproudhis, L; Bouguen, G

Bouguen, G (corresponding author), Serv Malad Appareil Digestif, 2 Rue Henri le Guillou, F-35033 Rennes, France.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021; 19 (2): 288

Abstract

BACKGROUND & AIMS: Infliximab increases the risk of infection in patients with inflammatory bowel diseases (IBD), but there is controversy over th......

Full Text Link